Talecris Biotherapeutics makes appointment
This article was originally published in Scrip
Executive Summary
Talecris Biotherapeutics (US) has named Drayton Virkler senior director of its investor relations department. He began his new position this month having served as director for US product management at Talecris's Hypermune franchise, which develops products to treat and prevent a range of potentially fatal infections. Before joining Talecris, Mr Virkler spent five years at GlaxoSmithKline in positions of increasing responsibility, including senior product manager for the migraine marketing team and product director for Advair (salmeterol plus fluticasone) marketing.